Clinical studies have shown that treatment with thymosin alpha 1 increases response to vaccination.
Stefan Gravenstein
Advertisement
Stefan Gravenstein is professor of medicine, Brown University and clinical director, quality improvement, at Quality Partners
Articles by Stefan Gravenstein
Advertisement
Latest Updated Articles
Influenza Vaccine Enhancement with Immunomodulating Peptide Thymosin Alpha 1Published: January 2nd 2010 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
How India’s Biotech Ecosystem Is Shifting Toward Innovation and Global Partnerships
2
Streamlining Procurement and Inventory Management Leads to Increased Productivity
3
Meeting Global Demand and Delivering Faster, More Reliable Service
4
Managing Risk and Minimizing the Complexity of Your Global Single-Use Supply Chain
5
